Chris Smiley
Optometrist · Columbus, OHNPI 1689679946
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $221,765 of the $305,195 with a category attached, or 72.7%. 19 manufacturers reported payments, led by Bausch & Lomb Americas Inc. at 44.3% of the total. Reporting peaked in 2019 at $59,423 and has fallen 61.8% since, to $22,681 in 2025. Among optometrist clinicians in OH with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 812 payments — averaging $375.86 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Bausch & Lomb Americas Inc.$135K
- Bausch & Lomb, A Division Of Bausch Health US, LLC$86K
- Sun Pharmaceutical Industries Inc.$37K
- AbbVie$33K
- Alcon$5K
- Coopervision Inc.$4K
- plus $4K from 13 others
What the payments were for
- Consulting fees$14,8755%
- Speaking & faculty fees$221,76573%
- Travel & lodging$44,55815%
- Food & beverage$23,9798%
- Education$180%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Bausch & Lomb Americas Inc. | 313 | $135,158 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 201 | $86,315 |
| Sun Pharmaceutical Industries Inc. | 56 | $37,452 |
| AbbVie(2 entities) | 87 | $33,185 |
| Alcon | 76 | $5,361 |
| Coopervision Inc. | 19 | $4,079 |
| Johnson & Johnson Vision Care, Inc. | 23 | $1,196 |
| Apellis Pharmaceuticals, Inc. | 2 | $775 |
| Oyster Point Pharma, Inc. | 13 | $394 |
| Sight Sciences, Inc. | 4 | $248 |
| Tarsus Pharmaceuticals, Inc. | 3 | $202 |
| Kala Pharmaceuticals, Inc. | 4 | $173 |
| Visionary Optics LLC | 1 | $149 |
| Biotissue Holdings Inc. | 2 | $143 |
| Harrow Eye, LLC | 3 | $138 |
| Optovue, Inc. | 1 | $117 |
| Lombart Brothers, Inc. | 1 | $48 |
| Dompe US, Inc. | 2 | $43 |
| Johnson & Johnson | 1 | $21 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- INFUSE$149,777
- BIOTRUE$40,054
- ULTRA$39,864
- BIOTRUE ONE DAY$39,425
- CEQUA$36,447
- VUITY$26,734
- ULTRA MULTIFOCAL TORIC$10,858
- INFUSE MULTIFOCAL$5,352
- MiSight Contact Lens$2,610
- Precision 1$2,281
- DAILIES TOTAL1$1,589
- LUMIGAN$1,007
- COMBIGAN$1,007
- Non-Product Brand Specific$1,000
- ALPHAGAN P$875
- XIIDRA$794
- MIEBO$794
- Syfovre$700
- DAILIES$639
- Acuvue$554
How this compares
$305,195 in reported general payments places this provider in the 95th percentile of 1,995 optometrist providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| RestasisCyclosporine | 33 | $42,482 |
| MieboPerfluorohexyloctane/Pf | 15 | $11,153 |
| Cyclosporine | 21 | $10,012 |
| Latanoprost | 65 | $551 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieRestasis | $33,185 | $42,48233 claims |
| Bausch & Lomb Americas Inc.Miebo | $135,158 | $11,15315 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 1,995 optometrist providers in Ohio.
Other optometrist in Columbus
- Gregory DenaeyerColumbus$846K
- Erin RueffColumbus$131K
- Kristen BurkholderColumbus$44K
- James OatneyColumbus$39K
- Kate McClureColumbus$18K
- Abigail MennerColumbus$18K
- Douglas BosnerColumbus$15K
- Jennifer FogtColumbus$13K
- Joseph BarrColumbus$11K
- Kimberly PattonColumbus$10K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.